(Original title: Novizan (688105.SH) released its 2021 performance net profit of 678 million yuan, down 17.46% year-on-year
Zhitong Finance APP News, Novozymes (688105.SH) disclosed its 2021 annual report. The company achieved operating income of 1.869 billion yuan in 2021, a year-on-year increase of 19.44%. The net profit attributable to shareholders of listed companies was 678 million yuan, a year-on-year decrease of 17.46%. The net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 644 million yuan, a year-on-year decrease of 20.9%. Basic earnings per share was 1.87 yuan per share. It is proposed to distribute a cash dividend of 3 yuan (tax included) for every 10 shares.
During the reporting period, the company’s profits declined, mainly due to the implementation of the policy of centralized procurement of medical devices and the intensified competition in the industry. Costs continue to increase.